Skip to content
10-Q

Quarterly Report

Aspira Women's Health Inc. AWHL

0001493152-25-011865

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 8, 2025 35.66M sh
Shares Diluted Q2 2025 · Jun 30, 2025 35.56M sh
Shares Diluted Q2 2025 · Jun 30, 2025 28.58M sh
Shares Diluted Q2 2025 · Jun 30, 2024 12.52M sh
Shares Diluted Q2 2025 · Jun 30, 2024 12.18M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$4.84M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$8.17M
Long Term Debt Q2 2025 · Jun 30, 2025 $1.16M
Long Term Debt Q2 2025 · Dec 31, 2024 $1.28M
Short Term Debt Q2 2025 · Jun 30, 2025 $154K
Short Term Debt Q2 2025 · Dec 31, 2024 $614K
Cash And Equivalents Q2 2025 · Jun 30, 2025 $1.55M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $1.77M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$2.69M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$2.56M
Current Liabilities Q2 2025 · Jun 30, 2025 $4.1M
Current Liabilities Q2 2025 · Dec 31, 2024 $5.47M
Total Liabilities Q2 2025 · Jun 30, 2025 $7.62M
Total Liabilities Q2 2025 · Dec 31, 2024 $8.05M
Current Assets Q2 2025 · Jun 30, 2025 $3.69M
Current Assets Q2 2025 · Dec 31, 2024 $4.18M
Total Assets Q2 2025 · Jun 30, 2025 $4.93M
Total Assets Q2 2025 · Dec 31, 2024 $5.49M
Total Assets restated Q2 2025 · Jun 30, 2024 $5.49M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.07
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.16
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.28
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.67
Eps Basic Q2 2025 · Jun 30, 2025 −$0.07
Eps Basic Q2 2025 · Jun 30, 2025 −$0.16
Eps Basic Q2 2025 · Jun 30, 2024 −$0.28
Eps Basic Q2 2025 · Jun 30, 2024 −$0.67
Sga Expense Q2 2025 · Jun 30, 2025 $1.96M
Sga Expense Q2 2025 · Jun 30, 2025 $4.7M
Sga Expense Q2 2025 · Jun 30, 2024 $2.73M
Sga Expense Q2 2025 · Jun 30, 2024 $5.85M
Rd Expense Q2 2025 · Jun 30, 2025 $704K
Rd Expense Q2 2025 · Jun 30, 2025 $1.68M
Rd Expense Q2 2025 · Jun 30, 2024 $952K
Rd Expense Q2 2025 · Jun 30, 2024 $1.86M
Net Income Q2 2025 · Jun 30, 2025 −$2.67M
Net Income Q2 2025 · Jun 30, 2025 −$4.52M
Net Income Q2 2025 · Mar 31, 2025 −$1.85M
Net Income Q2 2025 · Jun 30, 2024 −$3.53M
Net Income Q2 2025 · Jun 30, 2024 −$8.16M
Net Income Q2 2025 · Mar 31, 2024 −$4.63M
Operating Income Q2 2025 · Jun 30, 2025 −$1.81M
Operating Income Q2 2025 · Jun 30, 2025 −$5.05M
Operating Income Q2 2025 · Jun 30, 2024 −$4.39M
Operating Income Q2 2025 · Jun 30, 2024 −$9.1M
Gross Profit Q2 2025 · Jun 30, 2025 $1.53M
Gross Profit Q2 2025 · Jun 30, 2025 $3.09M
Gross Profit Q2 2025 · Jun 30, 2024 $1.42M
Gross Profit Q2 2025 · Jun 30, 2024 $2.64M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $870K
Cost Of Revenue Q2 2025 · Jun 30, 2025 $1.59M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $1M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $1.94M
Revenue Q2 2025 · Jun 30, 2025 $2.4M
Revenue Q2 2025 · Jun 30, 2025 $4.68M
Revenue Q2 2025 · Jun 30, 2024 $2.42M
Revenue Q2 2025 · Jun 30, 2024 $4.58M
Stock Issued Q2 2025 · Mar 5, 2025 200K sh
Capex Q2 2025 · Jun 30, 2024 $35K